 | • レポートコード：GIR-22F19670 • 出版社/出版日：GlobalInfoResearch / 2022年11月 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Topical Wound Agents Market 2022」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社の最新の調査によると、世界の局所創傷薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 局所創傷薬市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次をカバーします。 ・クリーム、ジェル、スプレー、その他 アプリケーション別セグメントは次のように区分されます。 ・急性創傷、慢性創傷 世界の局所創傷薬市場の主要な市場プレーヤーは以下のとおりです。 ・Anika Therapeutics Inc、Arch Therapeutics, Inc、Pfizer, Inc、Johnson & Johnson、Novartis AG、AstraZeneca、Viatris、Mölnlycke Health Care AB、Osiris Therapeutics、Smith & Nephew PLC、Teva Pharmaceuticals USA、Vericel Corporation 地域別セグメントは次の地域・国をカバーします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、局所創傷薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な局所創傷薬メーカーの企業概要、2019年～2022年までの局所創傷薬の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な局所創傷薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別局所創傷薬の販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までの局所創傷薬のタイプ別とアプリケーション別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での局所創傷薬市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、および局所創傷薬の産業チェーンを掲載しています。 ・第13、14、15章では、局所創傷薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 - 局所創傷薬の概要 - タイプ別分析（2017年vs2021年vs2028年）：クリーム、ジェル、スプレー、その他 - アプリケーション別分析（2017年vs2021年vs2028年）：急性創傷、慢性創傷 - 世界の局所創傷薬市場規模・予測 - 世界の局所創傷薬生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Anika Therapeutics Inc、Arch Therapeutics, Inc、Pfizer, Inc、Johnson & Johnson、Novartis AG、AstraZeneca、Viatris、Mölnlycke Health Care AB、Osiris Therapeutics、Smith & Nephew PLC、Teva Pharmaceuticals USA、Vericel Corporation ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：クリーム、ジェル、スプレー、その他 ・アプリケーション別分析2017年-2028年：急性創傷、慢性創傷 ・局所創傷薬の北米市場分析 - 局所創傷薬の北米市場：タイプ別市場規模2017年-2028年 - 局所創傷薬の北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・局所創傷薬のヨーロッパ市場分析 - ：局所創傷薬のヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：局所創傷薬のヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・局所創傷薬のアジア太平洋市場分析 - 局所創傷薬のアジア太平洋市場：タイプ別市場規模2017年-2028年 - 局所創傷薬のアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・局所創傷薬の南米市場分析 - 局所創傷薬の南米市場：タイプ別市場規模2017年-2028年 - 局所創傷薬の南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・局所創傷薬の中東・アフリカ市場分析 - 局所創傷薬の中東・アフリカ市場：タイプ別市場規模2017年-2028年 - 局所創傷薬の中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Topical Wound Agents market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Topical Wound Agents market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Acute Wound accounting for % of the Topical Wound Agents global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Cream segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Topical Wound Agents include Anika Therapeutics Inc, Arch Therapeutics, Inc, Pfizer, Inc, Johnson & Johnson, and Novartis AG, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Topical Wound Agents market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Cream
Gel
Spray
Others
Market segment by Application can be divided into
Acute Wound
Chronic Wound
The key market players for global Topical Wound Agents market are listed below:
Anika Therapeutics Inc
Arch Therapeutics, Inc
Pfizer, Inc
Johnson & Johnson
Novartis AG
AstraZeneca
Viatris
Mölnlycke Health Care AB
Osiris Therapeutics
Smith & Nephew PLC
Teva Pharmaceuticals USA
Vericel Corporation
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Topical Wound Agents product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Topical Wound Agents, with price, sales, revenue and global market share of Topical Wound Agents from 2019 to 2022.
Chapter 3, the Topical Wound Agents competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Topical Wound Agents breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Topical Wound Agents market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Topical Wound Agents.
Chapter 13, 14, and 15, to describe Topical Wound Agents sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Topical Wound Agents Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Topical Wound Agents Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Cream
1.2.3 Gel
1.2.4 Spray
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Topical Wound Agents Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Acute Wound
1.3.3 Chronic Wound
1.4 Global Topical Wound Agents Market Size & Forecast
1.4.1 Global Topical Wound Agents Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Topical Wound Agents Sales in Volume (2017-2028)
1.4.3 Global Topical Wound Agents Price (2017-2028)
1.5 Global Topical Wound Agents Production Capacity Analysis
1.5.1 Global Topical Wound Agents Total Production Capacity (2017-2028)
1.5.2 Global Topical Wound Agents Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Topical Wound Agents Market Drivers
1.6.2 Topical Wound Agents Market Restraints
1.6.3 Topical Wound Agents Trends Analysis
2 Manufacturers Profiles
2.1 Anika Therapeutics Inc
2.1.1 Anika Therapeutics Inc Details
2.1.2 Anika Therapeutics Inc Major Business
2.1.3 Anika Therapeutics Inc Topical Wound Agents Product and Services
2.1.4 Anika Therapeutics Inc Topical Wound Agents Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Arch Therapeutics, Inc
2.2.1 Arch Therapeutics, Inc Details
2.2.2 Arch Therapeutics, Inc Major Business
2.2.3 Arch Therapeutics, Inc Topical Wound Agents Product and Services
2.2.4 Arch Therapeutics, Inc Topical Wound Agents Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Pfizer, Inc
2.3.1 Pfizer, Inc Details
2.3.2 Pfizer, Inc Major Business
2.3.3 Pfizer, Inc Topical Wound Agents Product and Services
2.3.4 Pfizer, Inc Topical Wound Agents Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Johnson & Johnson
2.4.1 Johnson & Johnson Details
2.4.2 Johnson & Johnson Major Business
2.4.3 Johnson & Johnson Topical Wound Agents Product and Services
2.4.4 Johnson & Johnson Topical Wound Agents Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Novartis AG
2.5.1 Novartis AG Details
2.5.2 Novartis AG Major Business
2.5.3 Novartis AG Topical Wound Agents Product and Services
2.5.4 Novartis AG Topical Wound Agents Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 AstraZeneca
2.6.1 AstraZeneca Details
2.6.2 AstraZeneca Major Business
2.6.3 AstraZeneca Topical Wound Agents Product and Services
2.6.4 AstraZeneca Topical Wound Agents Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Viatris
2.7.1 Viatris Details
2.7.2 Viatris Major Business
2.7.3 Viatris Topical Wound Agents Product and Services
2.7.4 Viatris Topical Wound Agents Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Mölnlycke Health Care AB
2.8.1 Mölnlycke Health Care AB Details
2.8.2 Mölnlycke Health Care AB Major Business
2.8.3 Mölnlycke Health Care AB Topical Wound Agents Product and Services
2.8.4 Mölnlycke Health Care AB Topical Wound Agents Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Osiris Therapeutics
2.9.1 Osiris Therapeutics Details
2.9.2 Osiris Therapeutics Major Business
2.9.3 Osiris Therapeutics Topical Wound Agents Product and Services
2.9.4 Osiris Therapeutics Topical Wound Agents Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Smith & Nephew PLC
2.10.1 Smith & Nephew PLC Details
2.10.2 Smith & Nephew PLC Major Business
2.10.3 Smith & Nephew PLC Topical Wound Agents Product and Services
2.10.4 Smith & Nephew PLC Topical Wound Agents Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Teva Pharmaceuticals USA
2.11.1 Teva Pharmaceuticals USA Details
2.11.2 Teva Pharmaceuticals USA Major Business
2.11.3 Teva Pharmaceuticals USA Topical Wound Agents Product and Services
2.11.4 Teva Pharmaceuticals USA Topical Wound Agents Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Vericel Corporation
2.12.1 Vericel Corporation Details
2.12.2 Vericel Corporation Major Business
2.12.3 Vericel Corporation Topical Wound Agents Product and Services
2.12.4 Vericel Corporation Topical Wound Agents Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Topical Wound Agents Breakdown Data by Manufacturer
3.1 Global Topical Wound Agents Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Topical Wound Agents Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Topical Wound Agents
3.4 Market Concentration Rate
3.4.1 Top 3 Topical Wound Agents Manufacturer Market Share in 2021
3.4.2 Top 6 Topical Wound Agents Manufacturer Market Share in 2021
3.5 Global Topical Wound Agents Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Topical Wound Agents Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Topical Wound Agents Market Size by Region
4.1.1 Global Topical Wound Agents Sales in Volume by Region (2017-2028)
4.1.2 Global Topical Wound Agents Revenue by Region (2017-2028)
4.2 North America Topical Wound Agents Revenue (2017-2028)
4.3 Europe Topical Wound Agents Revenue (2017-2028)
4.4 Asia-Pacific Topical Wound Agents Revenue (2017-2028)
4.5 South America Topical Wound Agents Revenue (2017-2028)
4.6 Middle East and Africa Topical Wound Agents Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Topical Wound Agents Sales in Volume by Type (2017-2028)
5.2 Global Topical Wound Agents Revenue by Type (2017-2028)
5.3 Global Topical Wound Agents Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Topical Wound Agents Sales in Volume by Application (2017-2028)
6.2 Global Topical Wound Agents Revenue by Application (2017-2028)
6.3 Global Topical Wound Agents Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Topical Wound Agents Sales by Type (2017-2028)
7.2 North America Topical Wound Agents Sales by Application (2017-2028)
7.3 North America Topical Wound Agents Market Size by Country
7.3.1 North America Topical Wound Agents Sales in Volume by Country (2017-2028)
7.3.2 North America Topical Wound Agents Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Topical Wound Agents Sales by Type (2017-2028)
8.2 Europe Topical Wound Agents Sales by Application (2017-2028)
8.3 Europe Topical Wound Agents Market Size by Country
8.3.1 Europe Topical Wound Agents Sales in Volume by Country (2017-2028)
8.3.2 Europe Topical Wound Agents Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Topical Wound Agents Sales by Type (2017-2028)
9.2 Asia-Pacific Topical Wound Agents Sales by Application (2017-2028)
9.3 Asia-Pacific Topical Wound Agents Market Size by Region
9.3.1 Asia-Pacific Topical Wound Agents Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Topical Wound Agents Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Topical Wound Agents Sales by Type (2017-2028)
10.2 South America Topical Wound Agents Sales by Application (2017-2028)
10.3 South America Topical Wound Agents Market Size by Country
10.3.1 South America Topical Wound Agents Sales in Volume by Country (2017-2028)
10.3.2 South America Topical Wound Agents Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Topical Wound Agents Sales by Type (2017-2028)
11.2 Middle East & Africa Topical Wound Agents Sales by Application (2017-2028)
11.3 Middle East & Africa Topical Wound Agents Market Size by Country
11.3.1 Middle East & Africa Topical Wound Agents Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Topical Wound Agents Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Topical Wound Agents and Key Manufacturers
12.2 Manufacturing Costs Percentage of Topical Wound Agents
12.3 Topical Wound Agents Production Process
12.4 Topical Wound Agents Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Topical Wound Agents Typical Distributors
13.3 Topical Wound Agents Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer